BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/12/2026 11:20:19 AM | Browse: 1 | Download: 1
 |
Received |
|
2025-09-19 09:08 |
|
Peer-Review Started |
|
2025-09-19 09:09 |
|
First Decision by Editorial Office Director |
|
2025-09-25 09:20 |
|
Return for Revision |
|
2025-09-26 06:08 |
|
Revised |
|
2025-11-01 10:59 |
|
Publication Fee Transferred |
|
2025-11-08 11:04 |
|
Second Decision by Editor |
|
2025-12-11 02:43 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-11 08:17 |
|
Articles in Press |
|
2025-12-11 08:17 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-01 10:19 |
|
Publish the Manuscript Online |
|
2026-02-12 11:20 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shi-Peng Ma, Liang Wang, Yu-Liang Zhang, Xin Wan, Qian Liu, Yu-Lun Tang, Lajpat-Rai Malhi and Shan-Fei Ge |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chinese Foundation for Hepatitis Prevention and Control Muxin Research Fund of Chronic Hepatitis B |
MX202418 |
|
| Corresponding Author |
Shan-Fei Ge, Department of Infectious Diseases, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai Zheng Street, Donghu District, Nanchang 330006, Jiangxi Province, China. geshanfei2010@163.com |
| Key Words |
Chronic hepatitis B; Tenofovir amibufenamide; Entecavir; Estimated glomerular filtration rate; Drug safety |
| Core Tip |
This study provides the comparison of renal safety between tenofovir amibufenamide (TMF) and entecavir (ETV) in treatment-naive chronic hepatitis B patients. After propensity score matching, TMF showed significantly less decline in estimated glomerular filtration rate over 48 weeks than ETV. Baseline estimated glomerular filtration rate and triglyceride levels independently predicted abnormal renal function, highlighting TMF’s potential renal safety advantage over ETV and offering clinicians important insights for individualized antiviral therapy. |
| Publish Date |
2026-02-12 11:20 |
| Citation |
Ma SP, Wang L, Zhang YL, Wan X, Liu Q, Tang YL, Malhi LR, Ge SF. Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B. World J Hepatol 2026; 18(2): 114346 |
| URL |
https://www.wjgnet.com/1948-5182/full/v18/i2/114346.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v18.i2.114346 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
